Sarcoma and mesenchymal tumors Flashcards
Molecular features of sarcomas as a class
30% translocation-associated
70% complex karyotype
Translocations in alveolar rhabdomyosarcoma
PAX3-FOXO1A - 75%
PAX7-FOXO1A - 20%
PAX3 with various partners (FOXO4, NCOA1, NCOA2, AFX) - 5%
Translocations in alveolar soft part sarcoma
ASPSCR1-TFE3 - >95% of cases
Translocations in angiomatoid fibrous histiocytoma
EWSR1-CREB1 72%
EWSR1-ATF1 21%
FUS-AFT1 7%
EWSR1-CREM Rare
Molecular features in angiosarcoma, radiation associated
MYC amplification
Molecular features in atypical lipomatous tumor / well differentiated liposarcoma
HMGIC, CDK4, and MDM2 amplification
Translocations in biphenotypic sinonasal sarcoma
PAX3-MAML3 (most common)
PAX3-FOXO1
PAX3-NCOA1
PAX3-NCOA2
PAX3-WWTR1
Translocations in clear cell sarcoma of soft parts
EWSR1-ATF1 - 90%
EWSR1-CREB1 - 10%
EWSR1-CREM - Rare
Molecular features in clear cell sarcoma of the kidney
BCOR internal tandem duplications
Some overlap with renal sarcomas harboring BCOR-CCNB3 or YWAAE-NUTM2B
Translocations in dermatofibrosarcoma protuberans
COL1A1-PDGFB - 95% of cases
Rarely other PDGFB partners
Translocations in desmoplastic small round cell tumor
EWSR1-WT1 - >95% of cases
Translocations in low grade endometrial stromal sarcoma
JAZF1-SUZ12
JAZF1-PHF1
JAZF1-BCORL1
EPC1-PHF1
MEAF6-PHF1
BRD8-PHF1
MBTD1-CXorf67
Translocations in high grade endometrial stromal sarcoma
KDM2B-BREBBP
YWHAE-NUTM2B
ZC3H7B-BCOR
Translocations in epithelioid hemandioendothelioma
WWTR1-CAMTA1 - 85% of cases
TFE3-YAP1
Translocations in Ewing sarcoma and PNET/Ewing family of tumors
EWSR1-FLI1 (90%)
EWSR1-ERG (5%)
other EWSR1 partners: ETV1, ETV4, FEV, PATZ1, SP3, NFATC2, SMARCA5, POU5F1
FUS-ERG
FUS-FEV
Translocations in extraskeletal myxoid chondrosarcoma
EWSR1-NR4A3 (75%)
TAF15-NR4A3 (15%)
TCF12-NR4A3
TFG-NR4A3
HSPA8-NR4A3
NR4A3-FUS
Translocations in infantile fibrosarcoma
ETV6-NTRK3 (>95%)
EML4-NTRK3
BRAF fusions
Translocations in uterine epithelioid leioyosarcoma
NRA4A3-PGR and other PGR rearrangements
Translocations in uterine myxoid leiomyosarcomas
TRPS1-PLAG1
RAD51B-PLAG1
Translocations in low-grade fibromyxoid sarcoma
FUS-CRE3L2 (>95%)
FUS-CREB3L1 (less than 5%)
EWSR1-CREB3L1
Translocations in malignant tenosynovial giant cell tumor
CSF1-COL6A3
Translocations in mesenchymal chondrosarcoma
HEY1-NCOA2 (>90%)
Translocations in myoepithelial tumors of soft tissue
EWSR1-POU5F1
EWSR1-ZNF444
EWSR1-PBX1
EWSR1-PBX3
EWSR1-KLF17
EWSR1-ATF1
Translocations in myxoid liposarcoma
FUS-DDIT3 (90%)
EWSR1-DDIT3 (10%)
Translocations in myxoinflammatory fibroblastic sarcoma
TGFBR3-MGEA5
Translocations in ossifying fibromyxoid tumor
MEAF6-PHF1
EPC1-PHF1
EP400-PHF1
PHF1-TFE3
ZC3H7B-BCOR
CREBBP-BCORL1
KDM2A-WWTR1
Translocations in perivascular epithelioid cell tumor (PEComa)
TSC2 mutation (unless TFE3 rearranged)
PSF-TFE3
DVL2-TFE3
NONO-TFE3
RBMX-TFE3
RAD51B-RRAGB
HTR4-ST3GALI
RASSF1-PDZRN3
SCL4A10-ROS1
ROS1-NETO1
Translocations in PRDM10-rearranged soft tissue tumor
CITED2-PRDM10
MED12-PRDM10
Translocations in pseudomyogenic hemangioendothelioma
SERPINE1-FOSB (50%)
ACTB-FOSB (50%)
Translocations in primary pulmonary myxoid sarcoma
EWSR1-CREB1
Translocations in sclerosing epithelioid fibrosarcoma
EWSR1-CREB2L2
EWSR1-CREB2L1
RESR1-CREB3L3
FUS-CREB3L2
Translocations in solitary fibrous tumor
NAB2-STAT6 (>95%)
Translocations in spindle cell / sclerosing rhabdomyosarcoma
VGLL2-CITED2
NCOA2 fusions
or
MYOD1 L122R
Translocations in synovial sarcoma
SS18-SSX1 (65%)
SS18-SSX2 (35%)
Translocations in undifferentiated small round cell sarcomas
CIC-DUX4
CIC-DUX4L
CIC-FOXO4
CIC-NUTM1
NUTM2A-CIC
BCOR-CCNB3
BCOR-MAML3
BCOR ITDs
Translocations in acral fibroblastic spindle cell neoplasm
EWSR1-SMAD3